Children's Oncology Group's 2013 blueprint for research: Bone tumors

被引：153

作者：

Gorlick, Richard ^{[1
,2
]}

Janeway, Katherine ^{[3
]}

Lessnick, Stephen ^{[4
]}

Randall, R. Lor ^{[5
,6
]}

Marina, Neyssa ^{[7
,8
]}

机构：

[1] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat & Mol Pharmacol, Bronx, NY 10467 USA

[2] Childrens Hosp Montefiore, Div Pediat Hematol Oncol, Bronx, NY 10467 USA

[3] Dana Farber Childrens Hosp Canc Ctr, Dept Pediat Hematol Oncol, Boston, MA USA

[4] Univ Utah, Sch Med, Dept Oncol Sci,Div Pediat Hematol Oncol, Ctr Childrens Canc Res,Huntsman Canc Inst, Salt Lake City, UT USA

[5] Univ Utah, Orthopaed Huntsman Canc Inst, Salt Lake City, UT USA

[6] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA

[7] Lucile Packard Childrens Hosp, Palo Alto, CA USA

[8] Stanford Univ, Palo Alto, CA 94304 USA

来源：

PEDIATRIC BLOOD & CANCER | 2013年 / 60卷 / 06期

关键词：

blueprint; bone sarcoma; Ewing sarcoma; osteosarcoma; FACTOR-I-RECEPTOR; EWING SARCOMA FAMILY; PRIMITIVE NEUROECTODERMAL TUMOR; ONCOGENIC TRANSCRIPTION FACTOR; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; MURAMYL TRIPEPTIDE; PROGNOSTIC-FACTORS; PHASE-II; METASTATIC OSTEOSARCOMA;

D O I：

10.1002/pbc.24429

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the US, approximately 650 children are diagnosed with osteosarcoma and Ewing sarcoma (ES) each year. Five-year survival ranges from 65% to 75% for localized disease and <30% for patients with metastases. Recent findings include interval-compressed five drug chemotherapy improves survival with localized ES. In osteosarcoma a large international trial investigating the addition of ifosfamide/etoposide or interferon to standard therapy has completed accrual. For ES an ongoing trial explores the addition of cyclophosphamide/topotecan to interval-compressed chemotherapy. Trials planned by the Children's Oncology Group will investigate new target(s) including IGF-1R and mTOR in ES, and RANKL and GD2 in osteosarcoma. Pediatr Blood Cancer 2013; 60: 10091015. (c) 2012 Wiley Periodicals, Inc.

引用

下载

页码：1009 / 1015

页数：7

共 50 条

[41] Children's Oncology Group 2023 blueprint for research: Cancer care delivery research
Parsons, Susan K. P.
Beauchemin, Melissa P.
Dupuis, Lee
Sugalski, Aaron
Wolfson, Julie Anna J.
Santacroce, Sheila J. G.
Marchak, Jordan G.
Sung, Lillian E.
Roth, Michael E.
COG Canc Care Delivery Res Comm
PEDIATRIC BLOOD & CANCER, 2023, 70
[42] Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care
Esbenshade, Adam
Sung, Lillian
Brackett, Julienne
Dupuis, L. Lee
Fisher, Brian
Grimes, Allison
Miller, Tamara P.
Ullrich, Nicole J.
Dvorak, Christopher C.
PEDIATRIC BLOOD & CANCER, 2023, 70
[43] Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma
El-Mallawany, Nader Kim
Alexander, Sarah
Fluchel, Mark J.
Hayashi, Robert J.
Lowe, Eric
Giulino-Roth, Lisa
Wistinghausen, Birte
Hermiston, Michelle E.
Allen, Carl
COGNHLComm
PEDIATRIC BLOOD & CANCER, 2023, 70
[44] Children's Oncology Group's 2023 blueprint for research: Surgery
Gow, Kenneth W.
Lautz, Timothy B.
Malek, Marcus M.
Cost, Nicholas G.
Newman, Erika A.
Dasgupta, Roshni
Christison-Lagay, Emily R.
Tiao, Gregory M.
Davidoff, Andrew M.
OG Surgery Discipline Comm
PEDIATRIC BLOOD & CANCER, 2024, 71 (03)
[45] Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation
Kitko, Carrie L.
Bollard, Catherine M.
Cairo, Mitchell S.
Chewning, Joseph
Fry, Terry J.
Pulsipher, Michael A.
Shenoy, Shalini
Wall, Donna A.
Levine, John E.
PEDIATRIC BLOOD & CANCER, 2023, 70
[46] Children's Oncology Group 2023 blueprint: Nursing discipline
Zupanec, Sue
Herriage, Teresa
Landier, Wendy
COG Nursing Discipline, C. O. G. Nursing Discipline
PEDIATRIC BLOOD & CANCER, 2023, 70
[47] Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Metts, Jonathan
Xue, Wei
Gao, Zhengya
Ermoian, Ralph
Bradley, Julie A.
Arnold, Michael A.
Dasgupta, Roshni
Venkatramani, Rajkumar
Walterhouse, David
CANCER, 2023, 129 (11) : 1735 - 1743
[48] The Children's Oncology Group epidemiology program: Opportunities for cancer research
Ross, JA
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1363S - 1363S
[49] Implementation of Recommentations for Return of Research Results in the Children's Oncology Group
Ruccione, K.
Pyke-Grimm, K.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S409 - S410
[50] Psychological research in childhood cancer: The children's oncology group perspective
Armstrong, FD
Reaman, GH
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2005, 30 (01) : 89 - 97

← 1 2 3 4 5 →